CNE0000015P8
CNE0000015P8
KPC PHARMACEUTICALS INC
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 6.33B EUR | 5.91B EUR | 8.63B EUR | 9.51B EUR |
Enterprise Value | 7.83B EUR | 6.68B EUR | 9.74B EUR | 9.96B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | 184.94x | 34.09x |
Forward P/E | 6.06x | -- | -- | -- |
Price to Sales | 1.3x | 1.71x | 1.96x | 1.84x |
Price to Book | 1.3x | 1.22x | 1.65x | 1.77x |
EV/Revenue | 1.61x | 1.93x | 2.21x | 1.92x |
EV/EBITDA | -23.75x | -- | 56.31x | 31.8x |
Price to FCF (P/FCF) | -- | -- | -- | 34.82x |
EV/FCF | -- | -- | -- | 36.47x |
FCF Yield | -18% | -8.11% | -2.55% | 2.87% |